By Keira Collin
According to several studies, it is now established that NDMA linked to cancer. The chemical contain a cause-causing element. People, who suspect of developing cancer after using Zantac and Ranitidine, are entitled to filing Zantac Lawsuits. NDMA contamination, according to the plaintiffs’ claims and lawyers’ documents, is associated with NDMA contamination.
Basis of Lawsuits
People, who filed the lawsuits for NDMA contamination, brought allegation against Sanofi, the generic manufacturer of Zantac, and other defendants that they knew the risks of NDMA in Zantac but failed to issue warning to the public. People, suspected of developing stomach cancer and bladder cancer after the drug use, may qualify for compensation.
The Real Picture
Valisure is a Connecticut-based online pharmacy. In September, 2019, they informed FDA that it had found NDMA or N-Nitrosodimethylamine in some batches of Zantac and its generic Ranitidine.
Some big retailers such as Walmart, Walgreens, Rite Aid and CVS stopped prescription and over-the-counter sale of Zantac. On top of that, 14 generic manufacturers and Sanofi recalled their medicines in the USA.
On April 1, 2020, the FDA announced that it had made a request to the manufacturers of Ranitidine products to pull out prescription as well as over-the-counter medicines from the market. According to them, new FDA tests suggest a risk to consumers’ health.
The manufactures found NDMA contamination in prescription drugs even before Valisure came up with their finding. In 2018, contamination resulted into valsartan recalls and lawsuits. Valsartan was found to have been contaminated with NDMA in times of manufacturing whereas Zantac lawsuits claim Ranitidine is responsible for NDMA formation in the consumers’ body.
FDA Finding
FDA has already made it clear that daily NDMA intake beyond 96 nanograms, is injurious to health.
New FDA tests come up with an interesting finding that NDMA in Ranitidine may cross behind the acceptable level as set by FDA if the drug is stored under normal conditions or at higher temperatures. Testing also reveals that the longer the time since the drug was manufactured, the higher the NDMA level.
Zantac and Carcinoma
Patients, who have filed lawsuits against Zantac manufacturer, reported the close link between NDMA in Zantac and different types of cancer. Many patients, who were diagnosed with cancer, had no genetic markers or family history, according to the lawsuits. In fact, the doctors suspected that cancer in these patients was caused by an environmental factor. Exposure to NDMA or other toxin-containing chemicals is a potential environmental factor for causing cancer.
Patients, who took Zantac and were diagnosed with cancer, also developed Crohn’s disease and primary pulmonary hypertension (PPH). PPH is a disease of hypertension in lungs. It is a rare pulmonary disease that causes the blood vessels in lungs to become narrow and the condition leads to high pressure in pulmonary artery.
Crohn’s disease is a kind of inflammatory bowel disease that causes the digestive tract to suffer inflammation, which leads to abdominal pain, cramps, diarrhea and weight loss.
Organs usually affected by NDMA are brain, lungs, liver, stomach, kidneys and bladder, as per a report by WHO (World Health Organization).
